Literature DB >> 17114562

Comparison of CT venography with MR venography in cerebral sinovenous thrombosis.

N Khandelwal1, Ajay Agarwal, Rohit Kochhar, J R Bapuraj, Paramjeet Singh, S Prabhakar, S Suri.   

Abstract

OBJECTIVE: The purpose of this study was to compare cerebral CT venography with MR venography and determine the reliability of CT venography in the diagnosis of cerebral sinovenous thrombosis. SUBJECTS AND METHODS: Fifty patients who were clinically suspected of having cerebral sinovenous thrombosis, irrespective of age and sex, underwent cerebral CT venography and MR venography. Projection venograms were displayed using maximum-intensity-projection images for both CT venography and MR venography. The CT venograms were also displayed using the integral algorithm, which depicts the average intensity value of the first five voxels deep in relation to the model surface that is nearest the viewer, allowing direct visualization of the thrombus in the sinuses. All CT venograms and MR venograms were independently evaluated by experienced neuroradiologists.
RESULTS: Of these 50 patients, 30 patients were diagnosed as having cerebral sinovenous thrombosis on both CT venography and MR venography. The total numbers of sinuses involved were 81 and 77 (CT venography and MR venography). When MR venography was used as the gold standard, CT venography was found to have both a sensitivity and a specificity of 75-100%, depending on the sinus and vein involved.
CONCLUSION: CT venography is as accurate as MR venography for diagnosing cerebral sinovenous thrombosis.

Entities:  

Mesh:

Year:  2006        PMID: 17114562     DOI: 10.2214/AJR.05.1249

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

Review 1.  Investigating suspected cerebral venous thrombosis.

Authors:  R Smith; M D Hourihan
Journal:  BMJ       Date:  2007-04-14

2.  Unilateral Nonvisualization of a Transverse Dural Sinus on Phase-Contrast MRV: Frequency and Differentiation from Sinus Thrombosis on Noncontrast MRI.

Authors:  Y-M Chang; A L Kuhn; N Porbandarwala; R Rojas; V Ivanovic; R A Bhadelia
Journal:  AJNR Am J Neuroradiol       Date:  2020-01       Impact factor: 3.825

Review 3.  Diagnosis and management of cerebral venous thrombosis.

Authors:  Roya Behrouzi; Martin Punter
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

Review 4.  [Sinus thrombosis and idiopathic intracerebral hypertension: Thrombophilia and hormonal influence as potentially relevant causal connections].

Authors:  Rainer B Zotz
Journal:  Ophthalmologe       Date:  2015-10       Impact factor: 1.059

5.  The Occipital Emissary Vein: A Possible Marker for Pseudotumor Cerebri.

Authors:  A Hedjoudje; A Piveteau; C Gonzalez-Campo; A Moghekar; P Gailloud; D San Millán
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-09       Impact factor: 3.825

6.  Evaluation and management of a patient with possible cerebral venous thrombosis.

Authors:  Fernando Barinagarrementeria; Antonio Arauz
Journal:  Neurol Clin Pract       Date:  2014-10

Review 7.  Pediatric Stroke Imaging.

Authors:  Alexander Khalaf; Michael Iv; Heather Fullerton; Max Wintermark
Journal:  Pediatr Neurol       Date:  2018-07-09       Impact factor: 3.372

8.  Early Detection and Quantification of Cerebral Venous Thrombosis by Magnetic Resonance Black-Blood Thrombus Imaging.

Authors:  Qi Yang; Jiangang Duan; Zhaoyang Fan; Xiaofeng Qu; Yibin Xie; Christopher Nguyen; Xiangying Du; Xiaoming Bi; Kuncheng Li; Xunming Ji; Debiao Li
Journal:  Stroke       Date:  2015-12-15       Impact factor: 7.914

9.  Acute subarachnoid hemorrhage. An unusual clinical presentation of cerebral venous sinus thrombosis.

Authors:  Ali Hassan; Bakhtiar Ahmad; Zahoor Ahmed; Khalid W Al-Quliti
Journal:  Neurosciences (Riyadh)       Date:  2015-01       Impact factor: 0.906

10.  Early imaging characteristics of 62 cases of cerebral venous sinus thrombosis.

Authors:  Hui Qu; Meilan Yang
Journal:  Exp Ther Med       Date:  2012-11-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.